Emile Daraï
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emile Daraï has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Patrick Madelenat
3 shared publicationsChristophe Poncelet
Laboratoire de biologie cellulaire, INSERM U327, Faculté Bichat‐Claude Bernard Paris VII, Paris, France
2 shared publicationsA. Cortez
Service d'Anatomie Pathologique, Hôpital Tenon, AP‐HP, Paris, France
1 shared publicationAnne Claude Cremieux
1 shared publicationArnaud Fauconnier
1 shared publicationC. Quereux
CHU Reims, Service de Gynécologie, Institut Mère Enfant Alix de Champagne
1 shared publication
Latest Publications
- 1 September 2006
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 16 (5) , 1911-1917
Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions
- 1 September 2006
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 16 (5) , 1911-1917
Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions
- 15 December 2005
- Published by Wiley in Journal of Surgical Oncology
- Vol. 92 (4) , 337-343
Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours
Background We examined the expression of apoptosis‐related proteins in serous versus mucinous borderline ovarian tumours, in comparison with benign and malignant ovarian tumours. Materials and Methods Immunohistochemical expression of pro‐apoptotic (p53, p21, bax, bak, fas) and anti‐apoptotic proteins (bcl‐2, bcl‐x) was determined in 34 borderline (19 mucinous, 15 serous), 20 benign (10 mucinous, 10 serous) and 28 malignant ovarian tumours (9 mucinous, 19 serous). Results A difference in semi‐quantitative p53 expression was found between benign and borderline tumours (P = 0.01), but not between borderline and malignant tumours. Increased p21 expression was found in borderline versus benign tumours (P = 0.004). Bcl‐2 expression was lower in borderline than in benign (P = 0.01) and malignant tumours (P = 0.02). No difference in bax, bak, fas or bcl‐x expression was observed among the three tumour types. Higher percentage of p21 positive cells was found in serous than in mucinous borderline tumours (P < 0.001). Bcl‐2 expression was higher in serous than in mucinous forms of benign (P < 0.001), borderline (P < 0.001), and malignant tumours (P < 0.003). No difference in p53, bax, bak, fas or bcl‐x expression was observed between serous and mucinous borderline ovarian tumours. Conclusion Although p53 overexpression was a common feature of both mucinous and serous borderline tumours, p21 and bcl‐2 overexpression appeared specific to serous tumours. J. Surg. Oncol. 2005;92:337–343.
- 15 December 2005
- Published by Wiley in Journal of Surgical Oncology
- Vol. 92 (4) , 337-343
Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours
Background We examined the expression of apoptosis‐related proteins in serous versus mucinous borderline ovarian tumours, in comparison with benign and malignant ovarian tumours. Materials and Methods Immunohistochemical expression of pro‐apoptotic (p53, p21, bax, bak, fas) and anti‐apoptotic proteins (bcl‐2, bcl‐x) was determined in 34 borderline (19 mucinous, 15 serous), 20 benign (10 mucinous, 10 serous) and 28 malignant ovarian tumours (9 mucinous, 19 serous). Results A difference in semi‐quantitative p53 expression was found between benign and borderline tumours (P = 0.01), but not between borderline and malignant tumours. Increased p21 expression was found in borderline versus benign tumours (P = 0.004). Bcl‐2 expression was lower in borderline than in benign (P = 0.01) and malignant tumours (P = 0.02). No difference in bax, bak, fas or bcl‐x expression was observed among the three tumour types. Higher percentage of p21 positive cells was found in serous than in mucinous borderline tumours (P < 0.001). Bcl‐2 expression was higher in serous than in mucinous forms of benign (P < 0.001), borderline (P < 0.001), and malignant tumours (P < 0.003). No difference in p53, bax, bak, fas or bcl‐x expression was observed between serous and mucinous borderline ovarian tumours. Conclusion Although p53 overexpression was a common feature of both mucinous and serous borderline tumours, p21 and bcl‐2 overexpression appeared specific to serous tumours. J. Surg. Oncol. 2005;92:337–343.
- 1 January 2003
- Vol. 9 (1) , 273-84
Hepatocyte growth factor and c-Met in cervical intraepithelial neoplasia: overexpression of proteins associated with oncogenic human papillomavirus and human immunodeficiency virus.
High prevalence of squamous cervical intraepithelial neoplasia (CIN) linked to oncogenic human papillomavirus (HPV) exits in HIV-infected women. Hepatocyte growth factor (HGF) and its receptor, c-Met, promote cell proliferation and are involved in tumor progression. Nothing is yet known about their expression in low- and high-grade CIN. Therefore, the expression, localization, and behavior of HGF and c-Met in normal and dysplastic cervical epithelium were investigated. We studied normal cervical mucosa from 10 healthy women, and low- and high-grade cervical lesions, uninfected (condyloma acuminata) or infected with oncogenic HPVs, from 40 HIV-negative and 48 HIV-positive women, using in situ molecular techniques, immunocytochemistry and morphoquantitative methods. In 154 oncogenic HPV-infected CIN encountered in biopsy samples, the total number of epithelial cell layers increased significantly during lesion progression. This number was significantly higher in HIV-positive than in HIV-negative women for CIN1 and CIN2 (P < 0.025 to P < 0.01). In HIV-negative women, the number and percentage of HGF and c-Met immunostained cell layers, and the intensity of immunostaining were enhanced in oncogenic HPV-infected lesions as compared with normal mucosa and condyloma acuminata. The latter parameters were significantly higher in tissues of HIV-positive women (oncogenic HPV-infected CIN1 and CIN2, normal-appearing mucosa contiguous to CIN, condyloma acuminata) than in the corresponding tissues of HIV-negative women (P < 0.025 to P < 0.0001). Overexpression of HGF/c-Met complex strongly correlates with oncogenic HPV and HIV infection. This overexpressed complex may stimulate cell proliferation in condyloma acuminata and participate in tumor progression in oncogenic HPV-infected lesions.
- 1 January 2003
- Vol. 9 (1) , 273-84
Hepatocyte growth factor and c-Met in cervical intraepithelial neoplasia: overexpression of proteins associated with oncogenic human papillomavirus and human immunodeficiency virus.
High prevalence of squamous cervical intraepithelial neoplasia (CIN) linked to oncogenic human papillomavirus (HPV) exits in HIV-infected women. Hepatocyte growth factor (HGF) and its receptor, c-Met, promote cell proliferation and are involved in tumor progression. Nothing is yet known about their expression in low- and high-grade CIN. Therefore, the expression, localization, and behavior of HGF and c-Met in normal and dysplastic cervical epithelium were investigated. We studied normal cervical mucosa from 10 healthy women, and low- and high-grade cervical lesions, uninfected (condyloma acuminata) or infected with oncogenic HPVs, from 40 HIV-negative and 48 HIV-positive women, using in situ molecular techniques, immunocytochemistry and morphoquantitative methods. In 154 oncogenic HPV-infected CIN encountered in biopsy samples, the total number of epithelial cell layers increased significantly during lesion progression. This number was significantly higher in HIV-positive than in HIV-negative women for CIN1 and CIN2 (P < 0.025 to P < 0.01). In HIV-negative women, the number and percentage of HGF and c-Met immunostained cell layers, and the intensity of immunostaining were enhanced in oncogenic HPV-infected lesions as compared with normal mucosa and condyloma acuminata. The latter parameters were significantly higher in tissues of HIV-positive women (oncogenic HPV-infected CIN1 and CIN2, normal-appearing mucosa contiguous to CIN, condyloma acuminata) than in the corresponding tissues of HIV-negative women (P < 0.025 to P < 0.0001). Overexpression of HGF/c-Met complex strongly correlates with oncogenic HPV and HIV infection. This overexpressed complex may stimulate cell proliferation in condyloma acuminata and participate in tumor progression in oncogenic HPV-infected lesions.
- Open Access
- 1 March 2002
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 81 (3) , 195-203
Expression of cadherins and CD44 isoforms in human endometrium and peritoneal endometriosis
Background. To evaluate (a) cadherins and CD44 expression in normal endometrium and in peritoneal endometriosis, and (b) to correlate, their expressions with clinicopathological parameters.Methods. E‐ and N‐cadherin, CD44 isoforms, CD44v3 and CD44v6 expressions were evaluated: (a) by immunoblotting in endometrium (n = 6) and in peritoneal endometriotic samples (n = 7) and, (b) by immunohistochemistry in endometrium (n = 15) and in peritoneal endometriotic samples (n = 23).Results. By immunoblotting, endometrium expressed E‐ and N‐cadherin, CD44 isoforms, CD44v3 and CD44v6. Similar results were observed in peritoneal endometriosis. By immunohistochemistry, in endometrium, E‐cadherin was restricted to epithelial cells. Its expression remained constant throughout the menstrual cycle. N‐cadherin was detected in both epithelial and stromal cells in the proliferative phase but was restricted to epithelial cells in the secretory phase. CD44 immunostaining was detected in the secretory but not in the proliferative phase. Decreased expression of E‐cadherin (p < 0.01) and CD44 (p < 0.01) in epithelial cells was found in peritoneal endometriosis as compared with normal endometrium. In endometriotic stromal cells, decreased CD44 expression was found. In peritoneal endometriosis, we observed a decreased expression of E‐cadherin in advanced stages of the disease (p < 0.01).Conclusion. Our results suggest that E‐cadherin and CD44 proteins could be involved in the development of endometriotic lesions. Investigation of the mechanisms of altered adhesion molecule expression may contribute to the understanding of the behavior of endometriotic cells.
- 1 March 2002
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 81 (3) , 195-203
Open AccessExpression of cadherins and CD44 isoforms in human endometrium and peritoneal endometriosis
Background. To evaluate (a) cadherins and CD44 expression in normal endometrium and in peritoneal endometriosis, and (b) to correlate, their expressions with clinicopathological parameters.Methods. E‐ and N‐cadherin, CD44 isoforms, CD44v3 and CD44v6 expressions were evaluated: (a) by immunoblotting in endometrium (n = 6) and in peritoneal endometriotic samples (n = 7) and, (b) by immunohistochemistry in endometrium (n = 15) and in peritoneal endometriotic samples (n = 23).Results. By immunoblotting, endometrium expressed E‐ and N‐cadherin, CD44 isoforms, CD44v3 and CD44v6. Similar results were observed in peritoneal endometriosis. By immunohistochemistry, in endometrium, E‐cadherin was restricted to epithelial cells. Its expression remained constant throughout the menstrual cycle. N‐cadherin was detected in both epithelial and stromal cells in the proliferative phase but was restricted to epithelial cells in the secretory phase. CD44 immunostaining was detected in the secretory but not in the proliferative phase. Decreased expression of E‐cadherin (p < 0.01) and CD44 (p < 0.01) in epithelial cells was found in peritoneal endometriosis as compared with normal endometrium. In endometriotic stromal cells, decreased CD44 expression was found. In peritoneal endometriosis, we observed a decreased expression of E‐cadherin in advanced stages of the disease (p < 0.01).Conclusion. Our results suggest that E‐cadherin and CD44 proteins could be involved in the development of endometriotic lesions. Investigation of the mechanisms of altered adhesion molecule expression may contribute to the understanding of the behavior of endometriotic cells.
- 1 January 1998
- Published by Wiley
- Vol. 77 (4) , 451-457
Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy
- 1 January 1998
- Published by Wiley
- Vol. 77 (4) , 451-457
Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy